Sandhill Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.33M Sell
25,899
-1,898
-7% -$442K 0.54% 32
2025
Q4
$5.75M Sell
27,797
-220
-0.8% -$43.5K 0.41% 39
2025
Q3
$5.2M Sell
28,017
-1
-0% -$171 0.36% 42
2025
Q2
$4.28M Buy
28,018
+332
+1% +$51K 0.31% 47
2025
Q1
$4.59M Buy
27,686
+1,035
+4% +$162K 0.38% 41
2024
Q4
$3.85M Buy
26,651
+151
+0.6% +$23.4K 0.3% 48
2024
Q3
$4.29M Buy
26,500
+798
+3% +$127K 0.31% 46
2024
Q2
$3.76M Buy
25,702
+68
+0.3% +$10.1K 0.29% 46
2024
Q1
$4.06M Buy
25,634
+158
+0.6% +$25.1K 0.32% 43
2023
Q4
$3.99M Sell
25,476
-2,704
-10% -$415K 0.33% 41
2023
Q3
$4.39M Buy
28,180
+287
+1% +$47.4K 0.41% 41
2023
Q2
$4.62M Sell
27,893
-1,281
-4% -$207K 0.42% 36
2023
Q1
$4.52M Buy
29,174
+2,456
+9% +$397K 0.43% 42
2022
Q4
$4.72M Sell
26,718
-2,063
-7% -$356K 0.5% 41
2022
Q3
$4.7M Buy
28,781
+222
+0.8% +$37.6K 0.54% 34
2022
Q2
$5.07M Buy
28,559
+13,590
+91% +$2.42M 0.54% 34
2022
Q1
$2.65M Buy
14,969
+911
+6% +$155K 0.23% 39
2021
Q4
$2.4M Sell
14,058
-515
-4% -$84.3K 0.19% 43
2021
Q3
$2.35M Buy
14,573
+1,314
+10% +$224K 0.19% 39
2021
Q2
$2.18M Buy
13,259
+1,287
+11% +$213K 0.17% 39
2021
Q1
$1.97M Sell
11,972
-42
-0.3% -$6.8K 0.17% 41
2020
Q4
$1.89M Sell
12,014
-202
-2% -$29.8K 0.17% 41
2020
Q3
$1.82M Buy
12,216
+492
+4% +$72.8K 0.18% 42
2020
Q2
$1.65M Buy
11,724
+539
+5% +$78.5K 0.19% 41
2020
Q1
$1.47M Buy
11,185
+48
+0.4% +$6.81K 0.2% 43
2019
Q4
$1.63M Buy
11,137
+1,703
+18% +$231K 0.18% 40
2019
Q3
$1.22M Buy
9,434
+699
+8% +$92.1K 0.15% 40
2019
Q2
$1.22M Buy
8,735
+807
+10% +$112K 0.15% 36
2019
Q1
$1.11M Buy
7,928
+689
+10% +$92.3K 0.15% 35
2018
Q4
$934K Sell
7,239
-95
-1% -$13.3K 0.15% 38
2018
Q3
$1.01M Sell
7,334
-938
-11% -$125K 0.15% 38
2018
Q2
$1M Sell
8,272
-127
-2% -$15.8K 0.16% 37
2018
Q1
$1.08M Sell
8,399
-16
-0.2% -$2.16K 0.18% 37
2017
Q4
$1.18M Buy
8,415
+505
+6% +$70.3K 0.21% 33
2017
Q3
$1.03M Sell
7,910
-85
-1% -$11.3K 0.2% 34
2017
Q2
$1.06M Buy
7,995
+136
+2% +$17.3K 0.22% 32
2017
Q1
$979K Sell
7,859
-1,138
-13% -$136K 0.23% 31
2016
Q4
$1.04M Buy
8,997
+239
+3% +$27.6K 0.28% 28
2016
Q3
$1.03M Buy
8,758
+859
+11% +$104K 0.31% 27
2016
Q2
$958K Sell
7,899
-68
-0.9% -$7.73K 0.3% 27
2016
Q1
$862K Sell
7,967
-61
-0.8% -$6.32K 0.28% 28
2015
Q4
$825K Buy
8,028
+393
+5% +$39.5K 0.26% 27
2015
Q3
$713K Sell
7,635
-188
-2% -$18.2K 0.24% 30
2015
Q2
$762K Sell
7,823
-2,584
-25% -$259K 0.23% 35
2015
Q1
$1.05M Buy
10,407
+5
+0% +$508 0.36% 30
2014
Q4
$1.09M Buy
10,402
+1,206
+13% +$127K 0.37% 24
2014
Q3
$980K Buy
9,196
+1,918
+26% +$199K 0.35% 28
2014
Q2
$761K Buy
7,278
+406
+6% +$41K 0.28% 39
2014
Q1
$675K Buy
6,872
+1,213
+21% +$112K 0.26% 44
2013
Q4
$518K Buy
5,659
+370
+7% +$34.1K 0.21% 53
2013
Q3
$459K Sell
5,289
-94
-2% -$8.43K 0.21% 48
2013
Q2
$462K Buy
+5,383
New +$457K 0.23% 50

Other funds holding JNJ

Sandhill Capital Partners's JNJ Position: Q1 2026 in Review

Sandhill Capital Partners reduced its Johnson & Johnson (JNJ) stake by 6.8% in Q1 2026, selling an estimated $442K and leaving 25,899 shares worth $6.33M. The position accounts for 0.54% of the portfolio, ranked #32.

Sandhill Capital Partners first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,621 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sandhill Capital Partners held 25,899 shares of Johnson & Johnson worth $6.33M as of Q1 2026.
  • Sandhill Capital Partners sold 1,898 Johnson & Johnson shares in Q1 2026, an estimated $442K.
  • Johnson & Johnson made up 0.54% of Sandhill Capital Partners's portfolio in Q1 2026, its #32 holding.
  • Sandhill Capital Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,621 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sandhill Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.